文献速递其他结缔组织病

原发性干燥综合征患者小唾液腺活检诊断非霍奇金淋巴瘤的特征

Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

纳入诊断非霍奇金淋巴瘤(NHL)时行小唾液腺活检(mSGB)的原发性干燥综合征(pSS)患者24例,其中13例(54.2%)经mSGB组织学确诊NHL,10/13(76.9%)为唯一确诊部位。MALT淋巴瘤占23/24(95.8%),mSGB阳性者均为MALT淋巴瘤;作者建议pSS诊断时行mSGB并在怀疑NHL时随访复查。

要点

  • 24例pSS患者诊断NHL时行mSGB,13例(54.2%)经mSGB组织学确诊NHL。
  • mSGB是10/13(76.9%)患者唯一能确诊NHL的部位。
  • MALT淋巴瘤占23/24(95.8%),mSGB阳性者100%为MALT淋巴瘤。

核心结论

  • 对怀疑NHL的pSS患者,mSGB组织学使其中半数得以确诊NHL,MALT淋巴瘤占95.8%且mSGB阳性者均为MALT淋巴瘤,从而避免更具侵入性的活检。
  • 作者认为,应在pSS诊断时获取mSGB,并在怀疑NHL时于随访中重复。

研究设计与样本

  • 纳入诊断NHL时行mSGB的pSS患者,共24例(92.3%女性,平均年龄61.3岁)。

主要发现

  • 24例中13例(54.2%)为mSGB组织学揭示NHL(mSGB阳性),其中10/13(76.9%)mSGB是唯一能确诊NHL的部位。
  • MALT淋巴瘤见于23/24(95.8%)患者,mSGB阳性者中100%为MALT淋巴瘤。
  • mSGB阳性与mSGB阴性患者的pSS及淋巴瘤特征相当。
  • 13例mSGB阳性患者中8例(61.5%)和全部11例mSGB阴性患者接受了淋巴瘤治疗。
  • 从诊断至随访1年,5例未治疗患者不含NHL条目的ESSDAI保持稳定(7.4 vs 5.0;P = 0.33),19例治疗患者显著下降(15.8 vs 5.1;P = 0.004)。

关键数值与推荐

  • mSGB组织学确诊NHL者占13/24(54.2%)。
  • mSGB为唯一确诊NHL部位者占10/13(76.9%)。
  • MALT淋巴瘤占23/24(95.8%),mSGB阳性者中MALT淋巴瘤占100%。
  • 未治疗5例ESSDAI(不含NHL条目)7.4 vs 5.0(P = 0.33);治疗19例15.8 vs 5.1(P = 0.004)。

临床怎么用

  • 作者认为,对怀疑NHL的pSS患者,mSGB组织学可在半数患者中确诊NHL并避免更具侵入性的活检。
  • 作者建议,应在pSS诊断时获取mSGB,并在怀疑NHL时于随访中重复。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the contribution of minor salivary gland biopsy (mSGB) histology in diagnosing primary SS (pSS)-associated non-Hodgkin B-cell lymphoma (NHL). METHODS: pSS patients with mSGB at NHL diagnosis were included. RESULTS: Among the 24 patients (92.3% female, mean age 61.3 years) with an mSGB at NHL diagnosis, 13 (54.2%) had mSGB histology-revealed NHL (mSGB+); it was the only site enabling NHL diagnosis in 10/13 (76.9%) patients. Mucosa-associated lymphoid tissue (MALT) lymphoma was found in 23/24 (95.8%) patients; 100% of mSGB+ identified MALT lymphomas. pSS and lymphoma characteristics were comparable for mSGB+ and mSGB- patients. Eight (61.5%) of the 13 mSGB+ patients and all 11 mSGB- patients were treated for lymphoma. Between diagnosis and 1 year of follow-up, the ESSDAI without the NHL item remained stable (7.4 vs 5.0; P = 0.33) for the five untreated patients, while it decreased significantly for the 19 treated patients (15.8 vs 5.1; P = 0.004). CONCLUSION: For pSS patients with suspected NHL, mSGB histology enabled NHL diagnosis in half of them, MALT was found in 95.8% and all mSGB+ were MALT lymphomas, thereby avoiding more invasive biopsy. Our results suggest that mSGB should be obtained at pSS diagnosis and repeated during follow-up when NHL is suspected.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Parreau S, Nocturne G, Mariette X, et al. Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients. Rheumatology (Oxford). 2022. PMID: 34940802. doi:10.1093/rheumatology/keab949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。